via Harvard University
A novel gene-editing experiment seems to have permanently reduced LDL and triglyceride levels in monkeys.
What if a single injection could lower blood levels of cholesterol and triglycerides — for a lifetime?
In the first gene-editing experiment of its kind, scientists have disabled two genes in monkeys that raise the risk for heart disease. Humans carry the genes as well, and the experiment has raised hopes that a leading killer may one day be tamed.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cure for heart disease
- Colorado Springs Officials to Cover Firefighters' Out-of-Pocket Expenses for Treatment of Cancer and Other Issues
The city will pick up the tab for treatment related to certain kinds of cancer, heart disease and mental health issues.
- Heart Disease News
Cardio-Fitness Cuts Death and Disease by Nearly 20% Apr. 29 ... 2024 — A multicenter study has identified a potential new treatment for acute heart failure, a leading cause of hospitalization ...
- They say you can cure a broken heart, but an angry heart could be more dangerous for your health
Stress, agitation and anger could lead to heart problems — and a new study from the American Heart Association gives us fresh insight into why that is.
- nib teams up with cardiology provider to reduce heart disease readmissions
nib Group (nib) and cardiology provider Advara HeartCare have launched an initiative to tackle unplanned readmissions for heart disease patients.
- Cost of two lifesaving heart disease treatments slashed
The costs of the two lifesaving heart medicines have been slashed after they were added to the Pharmaceutical Benefits Scheme (PBS).Previously treatment for the two kinds of heart disorder ...
Go deeper with Google Headlines on:
Cure for heart disease
[google_news title=”” keyword=”cure for heart disease” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Gene editing
- Can HIV be cured using gene editing? We will soon find out
We will have to wait till 2024 for the first report on efficacy. Despite the availability of antiretroviral drugs, hundreds of thousands of people still die from Aids each year. A cure for the disease ...
- Buy Rating Affirmed for Prime Medicine, Inc. on Robust Preclinical Data and Prime Editing Technology Prospects
In a report released today, Kostas Biliouris from BMO Capital maintained a Buy rating on Prime Medicine, Inc. (PRME – Research Report), ...
- CRISPR-based gene editing treatment shows promise for rare eye disorder
Researchers at Oregon Health & Science University used an experimental CRISPR-based gene editing treatment in participants with a rare eye disorder that causes low vision and blindness. The results ...
- Crispr Therapeutics Q1 Earnings: Casgevy Launch Tip Of Gene Editing Iceberg
Crispr Therapeutics AG shows potential for future earnings with its gene editing therapy Casgevy, offering treatment for various diseases. Read more here.
- Editas Medicine’s Innovative In Vivo Gene Editing Approach and Positive Clinical Trial Prospects Bolster Buy Rating
Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
Go deeper with Google Headlines on:
Gene editing
[google_news title=”” keyword=”gene editing” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]